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Abstract: Peripheral Nerve Injuries are one of the most common causes of hand dysfunction caused by upper limb trauma 
but still current management has remained suboptimal. This review aims to explain the traditional view of 
pathophysiology of nerve repair and also describe why surgical management is still inadequate in using the new biological 
research that has documented the changes that occur after the nerve injury, which, could cause suboptimal clinical 
outcomes. Subsequently presentation and diagnosis will be described for peripheral nerve injuries. When traditional 
surgical repair using end-to-end anastomosis is not adequate nerve conduits are required with the gold standard being the 
autologous nerve. Due to associated donor site morbidity and poor functional outcome documented with autologous nerve 
repair several new advancements for alternatives to bridge the gap are being investigated. We will summarise the new and 
future advancements of non-biological and biological replacements as well as gene therapy, which are being considered as 
the alternatives for peripheral nerve repair. 
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INTRODUCTION 
 Injuries to peripheral nerves are extremely common in many 
types of upper limb trauma. Injury to peripheral nerves can 
cause extreme dysfunction in the hand for the patient disrupting 
their professional and leisure activities. It is therefore vital that 
adequate treatment is available to repair peripheral nerves to 
prevent permanent financial loss for the patient as well as the 
healthcare economy. Galen was the first to describe the concept 
of the nerve but it was Paulus Aegineta in the 7th century who 
documented the first nerve repair and wound closure as a 
military surgeon. Since this time immense research has taken 
place to understand nerve pathology and physiology. Currently 
surgical repair involves either reconstruction with direct end-to-
end anastomosis or by the insertion of nerve grafts. Despite the 
long history and major microsurgical research and improvement 
peripheral nerve repair remains a challenge to surgeons and still 
has suboptimal outcomes. This review aims to discuss the 
pathophysiology of nerve injuries including the limitations of 
surgical repair at a biological level. We will subsequently 
describe the current techniques, problems and advances in the 
surgical management of nerve injuries. 
PRESENTATION AND PATHOPHYSIOLOGY OF 
NERVE INJURIES 
 The smallest anatomical subunit of a nerve is a nerve 
fiber. Groups of nerve fibers are surrounded by an inner 
endoneurium to form fascicles. Each fascicle is bounded by 
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perineurium; which contributes to nerve strength and 
maintains the intra-fascicular pressure. Groups of fascicles 
are enclosed by the outer epineurium with loose areolar 
tissue surrounding it. 
 Peripheral nerve injuries in the upper extremity are 
extremely common. The typical patient is usually young, 
sustaining a laceration from metal sharp objects or machinery 
[1]. To make the diagnosis of a nerve injury it is important to 
take a detailed history especially with regards to the timing of 
the event as this will help with guiding treatment. Sensation can 
be tested using several methods. Vibration is tested using a 
turning fork, which can be useful to test, as usually deficits 
occur before subjective complaints. Two-point discrimination is 
tested by using a paper clip and good for testing group A axons 
slow fibers. Pick-up tests have shown to be useful to test 
sensibility and tactile gnosis where the patient picks up the 
instructed item from a table full of multiple objects [2, 3]. 
Sudomotor activity can be interestingly be assessed in children 
by the absence of wrinkling after water immersion or in adults 
using the sweat test [3]. Motor function should be tested as like 
the upper and lower limbs in neurological examination and 
graded from 0-5. Special tests can be used to support or confirm 
a nerve injury including electromyography (EMG), nerve 
conduction studies or electrical muscle stimulation. Most 
commonly nerve conduction studies are used which measures 
conduction velocities and responses to amplitudes of a nerve 
fiber, after a percutaneous depolarizing current is supplied. The 
test is assessing the number of remaining functional axons and 
the quality of the myelin sheath. These tests are useful only in 
compressive lesions and partial lesions 5-7 days post-injury. 
EMG studies test electrical potentials from muscle fibers after 
insertion of a needle directly into the muscle belly. Doppler 
studies are useful to assess the blood flow to the nerve, as 
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ischaemia can cause direct changes to the motor and sensory 
nerves. 
 The sequel of the nerve regeneration involves a series of 
regulated steps; understanding this sequel of events is important 
for determining timing and techniques of nerve repair [4]. 
 During the first few hours chromatolysis and swelling takes 
place in the cell body and nucleus [4]. Oedema and swelling 
then continues in the axonal stump for the first few days. Within 
two to three days Wallerian degeneration commences which 
involves axonal and myelin disintegration both in an antergrade 
and retrograde direction [4]. Antegrade Wallerian degeneration 
then continues with Schwann cells and macrophage infiltration 
to remove cell debris, leaving only the basement membrane for 
about 3-6 weeks [5]. Schwann cells then start to proliferate and 
organize guiding the axonal sprouts between the basement 
membranes of the two nerve ends [4]. Nerve regeneration then 
begins on the columns of Schwann cells called Bunger bands. 
The proximal intact axon then sprouts a growth cone. The 
lamellipodia and filopodia cytoplasmic extensions allow the 
axon to explore the new environment and help in guiding the 
repair. Actin found in the axon allows elongation, within the 
tube. Growth continues at the restricted rate of 1-3 mm/day but 
simultaneously scar tissue interferes with growth [4]. 
CLASSIFICATION OF NERVE INJURIES 
 Nerve injuries were classified into neuropraxia, axonotmesis 
and neurotmesis by Seddon et al. after his World War 2 
experience of nerve injuries, in injured soldiers [6]. Sunderland 
expanded on this classification according to histological 
diagnosis [7]. 
Neuropraxia (Sunderland Type 1) 
 This is an injury to the myelin sheath only [6]. The axonal 
sheath is preserved and consequently is classified as the least 
severe nerve injury [6]. This injury is usually a consequence of 
compression or stretching. No Wallerian degeneration occurs 
and recovery is to be expected within days or weeks [6]. 
Axonotmesis (Sunderland Type 2-4) 
 In this type of injury the axon is affected and Wallerian 
degeneration occurs distal to the injury site [6]. Type 2 injuries 
involve the axon only; Types 3 and 4 disrupt the endoneurium 
and perineurium respectively [6]. Type 2 injuries usually show 
full recovery but Types 3 and 4 are expected to fail. Type 4 
injuries usually require surgical intervention, with most 
surgeons advocating a 8-10 week wait to ensure that they do not 
improve spontaneously [6]. 
Neurotmesis (Sunderland Type 5) ‘Neuroma-in-Continuity’ 
 This is the most severe type of injury, which results in 
complete disruption of the nerve; with the epineurium being 
transected surgical intervention is required [6]. 
TIMING OF NERVE REPAIR 
 Primary repair is the optimal approach for peripheral 
nerve injuries taking place within the first couple of days [8]. 
Secondary repair takes place one week or more after the 
injury [8]. Partial injuries (15% of injuries) as a consequence 
of stretch or contusions are commonly managed with 
secondary repair [9-11]. For complete injuries the method of 
repair depends on what is found during exploration. If the 
epineurium is found to be neatly divided then primary repair 
without tension is usually undertaken but if the ends are 
ragged then a graft may be required [12]. 
TECHNIQUE OF NERVE REPAIR 
 There are four main steps to a primary end-to-end  
repair – the most commonly used nerve repair technique. 
1. Preparation – The nerve ends are prepared to get 
visible ends with necrotic tissue being removed with 
blades leaving two normal looking ends. Flexing the 
joint above the nerve injury and bone shortening can 
be given more length if this is required [13]. 
2. Approximation – The nerve ends are mobilized and 
brought together leaving a minimal gap by applying 
appropriate tension. Tensionless repairs have shown 
to have better outcomes. During the approximation 
the nerve ends can be mobilised but extensive 
intrafasicular dissection should be avoided [13]. 
3. Alignment – Bloods vessels must be aligned and 
proper rotational alignment undertaken [13]. 
4. Maintenance – The nerve repair is maintained by 
stitches into the epineurium, commonly 9-0 or 10-0 
non-absorbable sutures. Hence, it is the epineural 
repair that keeps the repair together. The sutures need 
to be placed to avoid malrotation of the nerve ends. 
Sometimes individual fasiscular groups are identified 
for attachment (group fascicular nerve repair). These 
types of repair are usually preferred for larger nerves 
where sensory and motor fibers can be repaired 
separately [14]. 
 Postoperatively nerve repairs should be protected by 
immobilization for 10-14 days and sometimes surgeons 
advocate up to six-weeks depending on the nerve injury 
severity and cause [13]. After this period full passive and 
active range of motion is initiated for rehabilitation [13]. 
Postoperatively axons may take time to learn how to process 
new information especially following sensory nerves [15, 
16]. Age is the most vital factor to determine the outcome of 
nerve repair and can account for 50% of the variance in 
success [17]. 
 Another technique that can be used to repair nerves is the 
end-to-side nerve repair, which involves the attachment of 
one or two distal injured nerve end to the side of the 
uninjured nerve ends. This is a useful technique when the 
ends are not available as sources of axons [18]. 
WHY IS REGENERATION FOLLOWING SURGICAL 
REPAIR INCOMPLETE? 
 Recent research has helped understand the limitations of 
surgical practice for peripheral nerve repair. As highlighted 
above the decision to operate is usually several months 
following the injury, when healing has not occurred. Over 
this time axotomy induces atrophy of motoneurons which is 
only partially reversible [19]. Furthermore the velocity of 
growth is only 1-3 mm/day and so there is time for 
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neurotrophic factor production in the distal segments of the 
nerve to fall preventing fast regeneration [20, 21]. A major 
factor affecting repair is that the axotomised nerve needs to 
cross the coaptation site, which occurs in a random manner 
otherwise the axon may fail to reach the distal stump 
altogether [22]. Another challenge affected gaining adequate 
repair is the misalignment of the motor and sensory axons. If 
motor axons mistakenly enter sensory end organs there are 
‘pruned’ in a process call preferential motor reinnervation 
[23]. Alternatively muscle axons towards muscle can result 
in random innervation of inappropriate muscles [24]. 
Furthermore, after a long period of inactivity the target 
muscles that the nerves are trying to reinnervate have 
undergone denervation-induced atrophy, causing adverse 
clinical outcomes [20]. 
OTHER TECHNIQUES REQUIRED FOR NERVE 
REPAIR 
Nerve Grafting 
 In severe nerve injuries the defect between the two nerve 
ends may be too large or cause inappropriate tension for end-
to-end repair; then a bridge is indicated, by using a nerve 
graft [25, 26]. Typically donor grafts are autologous sensory 
nerves including the medial or lateral antebrachial cutaneous 
nerves, dorsal cutaneous nerve branch of the ulnar nerve, 
lateral femoral cutaneous nerve and superficial sensory 
branch of the radial [25, 26]. The surgeon must take into 
account the length of the nerve gap to be repaired, donor site 
morbidity and dissection difficulty when considering the 
most appropriate nerve to use [25, 26]. Nerves should be 
grafted within six-months to achieve full recovery. Most 
surgeons agree to harvest 10-20% longer than the measured 
defect to allow for contraction [25, 26]. Postoperative 
splinting usually occurs for 1-14 weeks, to achieve adequate 
clinical outcome. In recent years alternatives are being 
sought for autologous nerve grafts as the ‘gold standard’ [27] 
for bridging the gap. Limitations of nerve harvesting include 
morbidity at the donor site, and that only 40-50% of patients 
achieve notable functional improvement [28]. Grafts are not 
always successful because the size and number of fascicles 
in the proximal and distal nerve stumps or the expressions of 
the neurotrophic factors is commonly not ideal for 
regeneration. 
Improving Autologous Nerve Grafts 
 One idea which is being investigated, is the application 
of growth factors to peripheral nerve lesion sites to sustain 
the regenerative pathway of axons, which results in a down 
regulation of nerve growth factor expression [29]. However, 
despite articles showing some encouraging evidence the 
timing of growth factors and delivery is still being refined 
[29]. Application of electrical stimulation to peripheral 
nerves has shown to improve peripheral nerve lesions gaps 
but has shown to shorten the delay of fibers crossing the 
nerve injury site and not the speed of fiber growth. The 
effects of ES have shown to be only short lasting, with no 
difference in effect after three months [30, 31]. Phototherapy 
is a new exciting frontier, that uses low-power laser therapy 
[32]. Despite improvements in axon regeneration and 
myelination, reports are limited to support the advantages of 
laser therapy [32]. 
Replacing Autologous Nerve Grafts 
 Autologous biological tissues (non-nerve grafts) have 
been considered as an alternative as they would be 
immunologically compatible and non-toxic. However, 
harvesting samples with appropriate size and dimensions is 
difficult. Tissues, which have proved useful in promoting a 
degree of axon regeneration, include blood vessels and 
freeze-thaw killed skeletal muscles [33, 34]. A different 
approach is to use non-autologous sources, to bridge the gap 
between nerve lesions. These tissues offer unlimited supply 
but have an associated immunogenic risk, including 
transmission of disease and graft versus host disease 
reactions. The treatment of allogenic nerves with 
freeze/thawing has shown to provide graftable nerve samples 
in clinical trials [35]. Several animal trials have shown 
encouraging results, including the ‘Advance Processed 
Cadaveric Nerve Graft’ (AxoGen, Inc, Alachua, Florida) and 
‘Neurogen Bovine Collagen Conduit’ (Interga) [36]. 
CONSIDERATIONS FOR REPLACEMENTS OF 
AUTOLOGOUS NERVE GRAFTS 
 When constructing a nerve conduit for nerve repair, four 
elements need to be taken into consideration: Firstly the 
scaffold for axonal proliferation, then the support cells for 
Schwann cells and lastly the growth factors and extracellular 
matrix. 
SCAFFOLDS 
 The scaffold serves to act as the structure for supporting 
axonal regeneration [37]. Natural materials have been tested 
including laminin, fibronectin and collagen due to their 
advantages of decreased toxic effect, improved 
biocompatibility and enhancement of the migration of 
support cells [37] but there is documented evidence that they 
loose their ability to regenerate when stored for long periods 
of time and there can be batch to batch variability [38]. 
Synthetic materials have been used and tested and although 
useful as can be manipulated to the exact configuration, 
long-term consequences of the conduit on the nerve are 
unknown. Clinically approved materials for bridging 
peripheral nerve injuries are few from the US Food and Drug 
Administration (FDA) and from the European Union with a 
Conformite European (or CE) certification. Currently one 
biodegradable nerve conduit (SaluBridge from SaluMedica) 
and four biodegradable nerve conduits (Neurotube from 
Synovis Micro Companies Alliance; NeuroMatrixTM or 
NeuroFlexTM from Collagen Matrix Inc.; Neurolac from 
Polyganics BV; NeuraGenTM from Integra Neuroscience) 
have received such approval. 
Supports Cells (SC), Growth Factors and the Extracellular 
Matrix (ECM) 
 Support cells (SCs) have shown to enhance axon 
migration and produce structural and adhesive ECM 
molecules which promote nerve regeneration. Investigators 
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have tried to take advantage of the function of the SC to 
produce CNS and PNS regeneration [39-41]. Numerous 
growth factors are involved with peripheral nerve repair 
including nerve growth factor (BGF), brain derive 
neurotrophic factor (BDNF), insulin like growth factor  
(IGF-1, IGF-2), platelet derived growth factors (PDGF), 
fibroblast growth factor (FGF), and ciliary neurotrophic 
factor (CNTF). These growth factors as explained above, can 
be directly incorporated into the nerve conduit [42-44]. 
 The extracellular matrix molecules are important for 
axonal extension and act as guiding the nerve regeneration. It 
has been found that ECM molecules including fibronectin, 
collagen and laminin incorporated into the conduit, act as a 
guidance channel and have had variable results [45, 46]. 
NERVE TRANSFERS 
 More recently nerve transfers are becoming more 
frequent. This procedure means less needed nerve fascicles 
from a donor nerve are transected, dissected and then 
attached to a more important distal nerve segment. This 
transforms a proximal nerve injury to a distal one with short 
regeneration [47]. This technique is useful for transferring 
nerve trunks in brachial plexus injuries. Examples include 
the thoracodorsal nerve to the deltoid muscle for axillary 
nerve lesions; pronator quadratus branch of the anterior 
interosseous never (AIN) to the motor branch of the ulnar 
nerve at the Guyon’s canal [47]. 
GENE THERAPY 
 Gene therapy offers another exciting alternative to 
autologous nerve grafts for enhancing peripheral nerve 
repair. The main advantages are that the transduced cells will 
express the gene for an extended period of time which is 
useful as the neurotrophic factors inserted usually have a 
short half life [48]. Furthermore, the expression in the 
selected cells is restricted to the cell at the site of the 
injection of the viral vector meaning the therapy is selective, 
localised and specific. Various vectors are being trialed and 
tested with different types of neurotrophic factors but the 
main three cellular targets for gene therapy are the Schwann 
cells, injured neurons and the muscles fibers. So far gene 
therapy has been successfully applied in rodent models to 
counteract the atrophy of spinal motor neurons following 
ventral root avulsion [49]. Furthermore, selective viral over 
expression of NGF in the sensory saphenous branch resulted 
in increased correct sensory reinnervation after injury, which 
could help the challenge of misrouting the regenerating 
sensory axons [50]. Lastly, studies have shown the long term 
expression of neurotrophic factors by Schwann cell in the 
injured nerve is possible with gene therapy [51, 52]. 
Unfortunately, there are several obstacles preventing the 
translation of successful animal results to humans, including 
choosing the correct factor and target cell, biosafety 
regarding vectors and long term risk including mutagenesis. 
CONCLUSION 
 Over the last decade there has been extensive research 
into alternatives for surgical repair, as the clinical outcome 
often remains inadequate [53-56]. Although the concept of 
using a nerve conduit for peripheral nerve repair is quicker 
for the surgeons and avoids harvesting morbidity, it has not 
resulted in better outcomes in the literature so far. Many 
growth factors have been indentified which influence nerve 
regeneration, which gives hope to the development of the 
ideal combination of growth factor and nerve conduit. It is 
clear that many conduits are currently being researched but 
they are still in their experimental stage with few being 
approved for clinical application. Similarly to other solutions 
for reconstructive surgery, the surgical advancements of the 
future to the surgical approach to peripheral nerve injuries 
will be focusing on cell and tissue modification and 
transplantation. 
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